Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
ZIM Laboratories Limited engages in the development, manufacture, and supply of generic pharmaceutical and nutraceutical products in India and internationally. It provides its products in pre- formulation intermediates and finished formulations in the oral solid dosage forms, such as pellets, taste-masked powders, directly compressible granules, tablets, capsules, dry syrup, and oral thin films. The company offers therapeutics in the areas of urology, gastroenterology, antibiotics, anti-infectives, cardiovascular, central nervous system, NSAIDs/pain analgesics, and vitamins and supplements. The company was founded in 1984 and is based in Nagpur, India.
Key Metrics
as of Sep 2026
Market Cap 674 Cr
P/E 182.00
Div Yield 0.00 %
Book Value โน55.40
52w High โน137.00
52w Low โน59.30
Face Value โน10.00
Quarterly Results
Rs. Crores ยท hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
93.05
102.85
107.81
88.39
71.43
108.52
95.40
89.72
82.00
117.39
95.82
85.26
67.01
Expenses
90.65
96.27
95.31
82.21
67.10
93.28
83.63
81.32
74.12
101.96
84.64
76.29
62.47
Operating Profit
2.40
6.58
12.50
6.18
4.33
15.24
11.77
8.40
7.88
15.43
11.18
8.97
4.54
OPM %
2.58
6.40
11.59
6.99
6.06
14.04
12.34
9.36
9.61
13.14
11.67
10.52
6.78
Other Income
0.99
6.16
1.71
2.04
1.48
1.55
1.76
1.32
0.98
1.53
1.11
1.42
0.63
Depreciation
5.17
4.90
4.85
4.83
4.79
5.23
4.77
4.97
4.92
3.87
3.58
3.72
3.66
Interest
3.64
3.31
3.43
3.16
3.30
2.91
2.73
2.89
2.86
2.28
1.70
1.22
1.73
Profit before tax
-5.42
4.53
5.93
0.23
-2.28
8.65
6.03
1.86
1.08
10.81
7.01
5.45
-0.22
Tax %
-28.60
27.37
28.16
47.83
-25.88
37.34
27.86
34.41
30.56
26.92
31.10
23.30
-36.36
Net Profit
-3.88
3.28
4.26
0.12
-1.69
5.42
4.35
1.22
0.76
7.89
4.83
4.18
-0.14
EPS in Rs
-0.72
0.61
0.87
0.02
-0.35
1.11
0.89
0.25
0.16
1.62
0.99
0.86
-0.03
Profit & Loss
Annual ยท Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
370.00 376.00 365.00 397.00 329.00 304.00 274.00 332.00 272.00 235.00 268.00 266.00
Expenses
341.00 332.00 325.00 345.00 292.00 267.00 255.00 289.00 238.00 203.00 238.00 278.00
Operating Profit
30.00 43.00 40.00 51.00 38.00 37.00 20.00 43.00 34.00 32.00 30.00 -12.00
OPM %
8.00 12.00 11.00 13.00 12.00 12.00 7.00 13.00 13.00 14.00 11.00 -4.30
Other Income
11.00 6.00 5.00 6.00 5.00 -3.00 5.00 2.00 9.00 5.00 -2.00 2.00
Interest
13.00 11.00 7.00 6.00 8.00 11.00 13.00 11.00 9.00 10.00 14.00 10.00
Depreciation
19.00 20.00 15.00 16.00 15.00 15.00 13.00 11.00 10.00 9.00 9.00 7.00
Profit before tax
8.00 18.00 23.00 36.00 19.00 9.00 -1.00 23.00 24.00 18.00 5.00 -27.00
Tax %
29.00 33.00 27.00 30.00 33.00 35.00 -216.00 30.00 24.00 -6.00 5.00 -19.00
Net Profit
6.00 12.00 17.00 25.00 13.00 6.00 2.00 16.00 18.00 19.00 5.00 -22.00
EPS in Rs
1.12 2.41 3.44 5.13 2.67 1.15 0.36 3.31 โ โ โ โ
Dividend Payout %
0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.00 4.00 4.00 16.00 0.00
Balance Sheet
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
54.00 49.00 49.00 49.00 16.00 16.00 16.00 16.00 8.00 8.00 8.00 8.00
Reserves
233.00 196.00 183.00 145.00 154.00 141.00 136.00 135.00 128.00 110.00 91.00 86.00
Borrowings
127.00 118.00 112.00 62.00 53.00 82.00 90.00 77.00 81.00 81.00 96.00 93.00
Other Liabilities
112.00 102.00 99.00 79.00 112.00 81.00 81.00 96.00 80.00 60.00 61.00 78.00
Total Liabilities
525.00 464.00 443.00 335.00 335.00 320.00 323.00 325.00 297.00 259.00 256.00 265.00
Fixed Assets
160.00 164.00 160.00 107.00 103.00 103.00 111.00 101.00 94.00 89.00 92.00 87.00
CWIP
89.00 66.00 40.00 26.00 11.00 10.00 10.00 13.00 8.00 4.00 3.00 6.00
Investments
18.00 13.00 8.00 8.00 8.00 8.00 8.00 5.00 0.00 0.00 0.00 0.00
Other Assets
258.00 222.00 234.00 193.00 213.00 199.00 194.00 206.00 195.00 166.00 161.00 172.00
Total Assets
525.00 464.00 443.00 335.00 335.00 320.00 323.00 325.00 297.00 259.00 256.00 265.00
Cash Flows
Annual ยท Rs. Crores โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016
Cash from Operating Activity
48.00 51.00 11.00 35.00 47.00 32.00 21.00 37.00 37.00 32.00 22.00
Cash from Investing Activity
-57.00 -41.00 -72.00 -35.00 -14.00 -6.00 -19.00 -23.00 -26.00 -7.00 -12.00
Cash from Financing Activity
28.00 -9.00 60.00 1.00 -33.00 -26.00 -2.00 -15.00 -10.00 -25.00 -10.00
Net Cash Flow
18.00 0.00 -1.00 1.00 0.00 0.00 0.00 -1.00 1.00 0.00 0.00
Free Cash Flow
12.00 13.00 -61.00 0.00 32.00 26.00 7.00 19.00 8.00 24.00 9.00
CFO/OP %
173.00 114.00 35.00 82.00 125.00 90.00 133.00 90.00 120.00 109.00 78.00
Ratios
Annual ยท Days / % โ latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
91.00 91.00 100.00 81.00 90.00 77.00 84.00 99.00 119.00 137.00 120.00 111.00
Inventory Days
208.00 188.00 173.00 99.00 171.00 125.00 144.00 126.00 134.00 108.00 88.00 104.00
Days Payable
170.00 156.00 133.00 109.00 186.00 150.00 168.00 165.00 172.00 137.00 109.00 144.00
Cash Conversion Cycle
129.00 123.00 140.00 71.00 75.00 52.00 60.00 61.00 81.00 108.00 99.00 71.00
Working Capital Days
29.00 48.00 55.00 61.00 59.00 41.00 40.00 41.00 37.00 55.00 35.00 38.00
ROCE %
5.00 8.00 10.00 17.00 12.00 10.00 5.00 15.00 13.00 14.00 13.00 โ
Shareholding Pattern
% holding โ latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
30.36
30.35
33.26
33.26
33.26
33.26
33.26
33.26
33.26
33.26
33.26
33.26
FIIs
0.03
0.00
0.02
0.00
0.03
0.01
0.21
0.00
0.00
0.01
0.00
0.00
DIIs
1.34
0.07
0.20
0.24
0.24
0.24
0.24
0.00
0.00
0.00
0.00
0.00
Public
68.28
69.57
66.52
66.52
66.46
66.49
66.29
66.73
66.74
66.74
66.74
66.75
No. of Shareholders
14,510
16,636
17,251
17,282
16,641
17,448
17,450
17,716
17,483
17,100
17,342
15,305
Corporate Actions
6 records
Back to all stocks